Kerry Group acquisition to see further research development
In an attempt to further develop expertise, technology and manufacturing capabilities, Kerry Group has acquired two biotechnology companies. The latest move will see the Group merging with biotech firms in Mexico and Germany. The firms, c-LEcta in Germany and Enmex in Mexico will further develop new research within the Group. According to Dr. Albert McQuaid, chief science and technology officer with Kerry, “the food and pharmaceutical industries are on…